Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
39.22
+0.72 (1.86%)
Oct 20, 2026, 12:22 PM EDT - Market open

Genmab Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, Genmab stock has a consensus rating of "Strong Buy" and an average price target of $44.4. The average 1-year stock price forecast is 13.22% higher than the current stock price, while the lowest is $33.5 (-14.57%) and the highest is $58 (+47.90%).

Price Target: $44.4 (+13.22%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$33.5$44.4$44$58
Change-14.57%+13.22%+12.20%+47.90%

Analyst Ratings

The average analyst rating for Genmab stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Sep '26Oct '26
Strong Buy991010910
Buy000111
Hold221111
Sell000000
Strong Sell000000
Total111111121112

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Morgan Stanley
Morgan Stanley
Hold
Reiterates
$35 → $42
HoldReiterates$35 → $42+7.10%Oct 20, 2026
Bank of America Securities
Bank of America Securities
Buy
Maintains
n/a
BuyMaintainsn/an/aOct 19, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$50
BuyReiterates$50+27.50%Oct 19, 2026
Truist Financial
Truist Financial
Buy
Maintains
$40 → $45
BuyMaintains$40 → $45+14.75%Oct 9, 2026
TD Cowen
TD Cowen
Buy
Reiterates
$43
BuyReiterates$43+9.65%Oct 5, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
4.70B
from 3.72B
Increased by 26.48%
Revenue Next Year
5.54B
from 4.70B
Increased by 17.83%
EPS This Year
1.29
from 1.77
Decreased by -27.29%
EPS Next Year
1.81
from 1.29
Increased by 40.19%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Jan 1, 2024Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.29B2.08B2.39B3.12B3.72B4.70B
Revenue Growth
-22.52%61.88%14.68%30.59%19.19%26.48%
Gross Profit
1.29B2.08B2.36B2.98B3.48B4.39B
Gross Margin
100.00%100.00%98.62%95.42%93.60%93.20%
Operating Income
451.68M900.43M772.00M1.02B1.25B1.25B
Net Income
452.29M783.33M631.00M1.13B963.00M794.73M
EPS
----1.771.29
EPS Growth
-----10.69%-27.29%
Forward PE
-----30.44
Free Cash Flow
----1.15B961.94M
No. Analysts
-----18
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High5.0B
Avg4.7B
Low4.4B

Revenue Growth

Revenue Growth202620272028
High
34.2%
Avg
26.5%
Low
19.4%

EPS Forecast

EPS202620272028
High1.69
Avg1.29
Low1.16

EPS Growth

EPS Growth202620272028
High
-4.7%
Avg
-27.3%
Low
-34.7%